Professor Yu-lung Lau, MBChB, MD (Hon), FRCPCH, FRCPS (Glas), FHKAM, FHKCPaed

Chief Director, Clinical Trials Centre, The University of Hong Kong

Chair Professor of Paediatrics, Doris Zimmern Professor in Community Child Health, Department of Paediatrics & Adolescent Medicine, The University of Hong Kong

Deputy Hospital Chief Executive for Teaching & Research, HKU-Shenzhen Hospital

Hong Kong, China


Prof YL Lau is currently Chair Professor of Paediatrics, Doris Zimmern Professor in Community Child Health, Chief Director of Clinical Trials Centre of the University of Hong Kong, and Deputy HCE for Teaching & Research of the HKU Shenzhen Hospital.
Prof Lau established the Asian Primary Immunodeficiencies Network offering e-consultation and free genetic tests for such patients in China, SE Asia and N/S Africa. For lupus genetics, he has set up the Asian Lupus Genetics Consortium with collaborators from China and Thailand. He is currently the President of the Asian Society for Pediatric Research and Vice President of the Hong Kong College of Paediatricians. He with over 60 colleagues from 14 countries & regions in Asia established a new Asia Pacific Society for Immunodeficiencies in April 2015, Osaka.
He has worked towards the implementation of universal pneumococcal vaccination in 2009 in his capacity as the Chairman of the Working Group on Pneumococcal Vaccination. He also steered the process of introducing the universal screening for HIV infection in pregnant mothers back in 2001, in his capacity as the Chairman of the Scientific Committee on AIDS. He is currently the Chairman of the National Committee for the Certification of Wild Poliovirus Eradication. He has been the Principal Investigator for several international vaccine trials. Prof Lau has published over 300 original papers and supervised over 30 graduate students. He is among the top 1% highly cited researchers in the world according to Essential Science Indicators with total citation of >9000& H-index of 52.

20th November 2015 (Friday) 14:00 – 15:30
Session I: Pre-clinical Oncology Research